new glp-1 agonists England Journalist of Medicine published great article. Read it to learn more about the science behind medications. GLP-1 receptor are increasingly used to treat type 2 diabetes and obesity Machine learning designs new GCGR/GLP-1R
Description
While most people taking GLP-1s deal with daily discomfort rather than emergencies, Carroll says that there are some serious complications worth knowing about, including acute pancreatitis, gallbladder disease, and severe dehydration from prolonged vomiting or diarrhea
Diabetes 60, 12701276 (2011)
All content is framed for research use only no clinical or therapeutic claims are made
Clinical trials demonstrated 13.7 percent average body weight loss at 72 weeks, with many participants exceeding 15 percent
